Patents by Inventor Wayne E. Barth

Wayne E. Barth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 3966719
    Abstract: Certain novel antibacterial 7-acylamino-3-substituted-4-(tetrazol-5-yl)-.DELTA..sup.3 -cephem derivatives, and salts thereof, and intermediates useful in their preparation.
    Type: Grant
    Filed: September 23, 1974
    Date of Patent: June 29, 1976
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 3957784
    Abstract: 5-Carboxypyrimidine derivatives and their pharmaceutically acceptable basic salts, and their use as antiallergy agents.
    Type: Grant
    Filed: January 14, 1975
    Date of Patent: May 18, 1976
    Assignee: Pfizer Inc.
    Inventor: Wayne E. Barth
  • Patent number: 3933830
    Abstract: Disclosed herein is an improved process for the preparation of known hypoglycemic piperidinesulfamylureas of the structure ##EQU1## wherein R is selected from the group consisting of 3-(2-methoxy)pyridyl, 3-(2-ethoxy)pyridyl and 2-(4-chloro)pyridyl and R' is selected from the group consisting of bicyclo[2.2.1]hept-5-en-2-yl-endo-methyl, bicyclo[2.2.1]hept-2-yl-endo-methyl, 7-oxabicyclo[2.2.1]hept-2-yl-methyl, 1-adamantyl and cycloalkyl having from five to eight carbon atoms.Said process comprises contacting 4-(2-pyridyl-amidoethyl) piperidine of the structure ##EQU2## with substantially one equivalent of sulfamide thereby exclusively sulfonating the piperidine nitrogen atom.
    Type: Grant
    Filed: September 10, 1974
    Date of Patent: January 20, 1976
    Assignee: Pfizer Inc.
    Inventors: Wayne E. Barth, Donald E. Kuhla
  • Patent number: 3932325
    Abstract: A process is described for the preparation of 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide, a key intermediate in the synthesis of the known useful psychotherapeutic agents: chlorodiazepoxide and diazepam. This intermediate is prepared by the cyclization of 2-(1'-chloroimino-2'-chloromethyl)-5-chlorobenzophenone, itself a new compound. This compound in turn is prepared by the chloroacetylation of 2-amino-5-chlorobenzophenone to 2-chloroacetamido-5-chlorobenzophenone, another novel compound, and subsequent iminochloride formation.
    Type: Grant
    Filed: September 23, 1974
    Date of Patent: January 13, 1976
    Assignee: Pfizer Inc.
    Inventors: Susumu Nakanishi, Wayne E. Barth